Seok-gu K. Kang

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 166 publications

Survival analysis of adult midline-located gliomas and diffuse midline gliomas: beyond the H3K27 mutation paradigm.

Survival analysis of adult midline-located gliomas and diffuse midline gliomas: beyond the H3K27 mutation paradigm.

Journal: Journal of neuro-oncology

Published: April 07, 2026

NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.

NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.

Journal: Experimental & molecular medicine

Published: March 22, 2026

Beyond the Tumor Mass: From Initiating Clones to Overt Isocitrate Dehydrogenase-Mutant Gliomas.

Beyond the Tumor Mass: From Initiating Clones to Overt Isocitrate Dehydrogenase-Mutant Gliomas.

Journal: DNA and cell biology

Published: March 20, 2026

Extended Reality in Neurosurgery : Surgical Planning, Navigation, Education, and Patient Communication.

Extended Reality in Neurosurgery : Surgical Planning, Navigation, Education, and Patient Communication.

Journal: Journal of Korean Neurosurgical Society

Published: February 13, 2026

IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation.

IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation.

Journal: Science (New York, N.Y.)

Published: January 08, 2026

Improved tumor control with adjuvant radiotherapy in patients with central neurocytoma: a multicenter study.

Improved tumor control with adjuvant radiotherapy in patients with central neurocytoma: a multicenter study.

Journal: Journal of neuro-oncology

Published: January 06, 2026

Neoadjuvant gamma knife surgery for metastatic brain tumor: clinical use and impact on leptomeningeal seeding.

Neoadjuvant gamma knife surgery for metastatic brain tumor: clinical use and impact on leptomeningeal seeding.

Journal: Journal of neuro-oncology

Published: October 29, 2025

Clinical and molecular characteristics and prognostic factors of diffuse astrocytoma, IDH-wildtype, not elsewhere classified.

Clinical and molecular characteristics and prognostic factors of diffuse astrocytoma, IDH-wildtype, not elsewhere classified.

Journal: Journal of neuro-oncology

Published: October 19, 2025

Portable duplex digital PCR for on-site detection of IDH mutations in gliomas.

Portable duplex digital PCR for on-site detection of IDH mutations in gliomas.

Journal: Biosensors & bioelectronics

Published: August 09, 2025

The new Bruton's tyrosine kinase inhibitors SPA8007 and SPA8009 reduce stemness and invasiveness of patient-derived glioblastoma tumorspheres.

The new Bruton's tyrosine kinase inhibitors SPA8007 and SPA8009 reduce stemness and invasiveness of patient-derived glioblastoma tumorspheres.

Journal: Translational oncology

Published: April 22, 2025

Focused ultrasound-mediated temozolomide delivery into intact blood-brain barrier tissue improves survival in patient-derived xenograft model of glioblastoma.

Focused ultrasound-mediated temozolomide delivery into intact blood-brain barrier tissue improves survival in patient-derived xenograft model of glioblastoma.

Journal: Fluids and barriers of the CNS

Published: April 07, 2025

Tumor suppressive effect of low-frequency repetitive transcranial magnetic stimulation on glioblastoma progression.

Tumor suppressive effect of low-frequency repetitive transcranial magnetic stimulation on glioblastoma progression.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: November 06, 2024

Showing 1-12 of 166

Last Updated: 09/26/2026